DevelRx continues its medical education support for psychiatrists and other healthcare providers treating attention deficit hyperactivity disorder. At the invitation of Takeda Pharmaceuticals, David Heal will be presenting a lecture entitled “How can pharmacology help determine treatment choice in ADHD?” at the Dutch Paediatric Society (NVK; Nederlandse Vereniging voor Kindergeneeskunde) Virtual Meeting on Thursday December 17th, 15.30-16.00h (UK time).
DevelRx continues its medical education support for psychiatrists and other healthcare providers treating attention deficit hyperactivity disorder.
Biocity,
Pennyfoot Street,
Nottingham,
Nottinghamshire,
NG1 1GF